4 acke mips version 2
TRANSCRIPT
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 1/39
www.mips.be
Software Validation and Testing
Geert AckeQuality Manager MIPS (Clinisys)
22/04/2008
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 2/39
www.mips.be
Agenda
MIPSCompanyProducts
MIPS product development processDefect preventionDefect correction
Q&A
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 3/39
www.mips.be
We offer Solutions to improvethe efficiency of clinical
laboratories
Based on
Standardized Software andCustomized Services and Support tomeet specific customer requirements
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 4/39
www.mips.be
Group Operating structure
.
MIPS
Europe
CliniSys
UK & Ireland
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 5/39
www.mips.be
Group Global Coverage – Local Delivery
200 Dedicated
Healthcare IT Professionals
Over 850 Sites Using
CliniSys’ Solutions
Supporting 100,000
Healthcare Professionals
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 7/39
www.mips.be
Agenda
MIPSCompanyProducts
MIPS product development processDefect preventionDefect correction
Q&A
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 8/39
www.mips.be
MIPS products
GlimsGlims Laboratory information system (LIS)
SamplenetSamplenet Data manager
CyberlabCyberlab Result consultation via Intranet /Internet and electronic order entry
Drivers Interface with IVD MD and HIS
ArchieArchie XML Archiving
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 9/39
www.mips.be
Remote order entry
Remote result consultation
Laboratory clients
Data Manager or Concentrators
Connection with hospital
information system Direct bidirectional connections
Specialised in large complex IT-solutions forclinical laboratries
LIS
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 10/39
www.mips.be
Cyberlab
Web based Result consulting and Order entry system
Real-time result consultation for wards /outpatient clinics/GP
Electronic order entry for wards / outpatient clinics / GP
Reporting management
Can be interfaced with any LIS
Can be integrated in an EPR
Better interaction between the lab and its end users
Better service for hospital
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 11/39
www.mips.be
Remote order
entry
Remote result consultation
Laboratory clients
Data Manager or Concentrators
Connection with hospital
information system Direct bidirectional connections
with analyzers
Specialised in large complex IT-solutions forclinical laboratories
LIS
Drivers
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 12/39
www.mips.be
GLIMS covers following labs: Biochemistry
Toxicology
Immunology
Blood transfusion
Epidemiology
HLA / Histocompatability
Microbiology
Bacteriology – Parasitology – Serology - Virology
Hematology and coagulation Anticoagulants treatments
Immuno-hematology
Statistics :
Microbiology - Activity - Financial -Blood transfusion - Histology
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 13/39
www.mips.be
Leading European LIS Supplier Market leader in Netherlands (50+) and Belgium (90+)
Pre-configured solution for Partezis, 22 hospitals in Belgium
Rapid growth in France (50+) and Spain
France: Deploying standard solution to 15 hospitals in AP-HP group in Paris –centrally hosted Spain : bioMérieux distribute pre-configured microbiology solution
20 years history of successful deployment 200 pathology specialists 400+ LIMS installations in 10 countries Scaleable solutions ranging from small private lab through to large,
complex, multi-site pathology network Multi-lingual solutions
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 14/39
www.mips.be
LIS Market Share in Mature Markets
0
10
20
30
40
50
60
Netherlands Belgium UK Ireland
%
a g e s h a r
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 15/39
www.mips.be
Remote order
entry
Remote result consultation
Laboratory clients
Data Manager or Concentrators
Connection with hospital
information system Direct bidirectional connections
with analyzers
Specialised in large complex IT-solutions forclinical laboratories
LIS
Drivers
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 16/39
www.mips.be
Drivers
More then 250 different analyzers are currently in usewith Glims. Over the years, in total 600 analyzers have been
interfaced with Glims.
GLIMS is able to communicate with several hospitalinformation systems simultaneously to supportlaboratories servicing several hospitals.
The standards supported include HL7, HL7-XML, HPRIM,LDT, ASTM, XML,CPAGE and Edifact
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 17/39
www.mips.be
AgendaMIPS
CompanyProducts
MIPS product development processDefect preventionDefect correction
Q&A
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 18/39
www.mips.be
Pro-active : Defect prevention Development process includes
Safety risk management process Guided by IVD MD FDA and ISO regulations
Multiple reviews
Re-active : Defect correction Verification : Did we make it right ? Validation : Did we make the right thing ?
MIPS product development process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 19/39
www.mips.be
An effective risk management program encourages
a defect prevention mindset
Safety risk management can prevent safety relatedproblems
Safety risk management provides a basis for
defining different levels of test and review
Safety risk management encourages defensive
design practices
Safety risk management reduces civil liability as
well as satisfies regulatory requirements
DP: Safety risk management process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 20/39
www.mips.be
1. RiskAnalysis
2. RiskEvaluation
3. RiskControl
4. PostProductionInformation
Formal analysis methods (FMEA and FTA)Regulatory standards complianceHistorical analyses
Evaluate severityDefine safety requirementAssign probabilityEvaluate residual risk
Define controls and
perform residual riskevaluation
Review adequacy of safetyfor changes and defects
DP: Safety risk management process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 21/39
www.mips.be
Pro-active : Defect prevention Development process includes
Safety risk management process Guided by IVD MD FDA and ISO regulations
Multiple reviews
Re-active : Defect correction Verification : Did we make it right ? Validation : Did we make the right thing ?
MIPS product development process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 22/39
www.mips.be
SW modification life cycle
Documenter Documenter
Tester Tester
UnassignedUnassigned
Code reviewer Code reviewer
Programmer Programmer
Analyst Analyst
Product coordinator Product coordinator
Analysis
Analysis
review
Code
Code review
Delta
Test
Final review
Documentation
Discontinued
Committed
On hold
Defect prevention: Multiple reviews
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 23/39
www.mips.be
AgendaMIPS
CompanyProducts
MIPS product development processDefect preventionDefect correction
Q&A
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 24/39
www.mips.be
Pro-active : Defect prevention Development process includes
Safety risk management process Guided by IVD MD FDA and ISO regulations
Multiple reviews
Re-active : Defect correction Verification : Did we make it right ? Validation : Did we make the right thing ?
MIPS product development process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 25/39
www.mips.be
DC: Verification and Validation processRoadMap
Start Develpment
Start Integration
Testing
End Development
End Integration
Testing
Start Beta Testing
End Beta Testing
Beta
Release
GA Release
Alfa
Release
Unit Testing
Development
Analysis
Gateway
New Features
Integration
Regression
Beta Test
Scenarios
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 26/39
www.mips.be
DC: Verification – unit testing process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 27/39
www.mips.be
DC: Verification -integration testing process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 28/39
www.mips.be
DC: Verification -integration testingprocess
Verification and Validation process : How ? Structured Testing
Lifecycle of Structured Testing: LST (Tmap)
Planning & Control
Preparation
Specification
Execution
Completion
P - C
CP S E
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 29/39
www.mips.be
Test Planning & Control
MIA (MIPS Internal Application)
MS Project
Access (ODBC on MIA) Pivot Tables and Charts
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 30/39
www.mips.be
Test Preparation
MIA: Modification and Incidents Logs
SSD (Software Specification Document)
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 31/39
www.mips.be
Test Specification
Test Case Specification Document Test Cases (if applicable)
Pre-condition Test case
Expected result
Test Data (if applicable)
Test System Requirement (if applicable)
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 32/39
www.mips.be
Test Execution (1)
Test Case Specification document executed and logged in MIA(icl. attachments) Traceability
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 33/39
www.mips.be
Test Execution (2) Unit test fails: Solution
“rejected” and send backto developer
Integration test fails:
“Failure” documented andautomatically generatedincident
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 34/39
www.mips.be
Test Control
Test Progress Reporting
Formal Test Plan and Report (if applicable)
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 35/39
www.mips.be
Pro-active : Defect prevention Development process includes
Safety risk management process Guided by IVD MD FDA and ISO regulations
Multiple reviews
Re-active : Defect correction Verification : Did we make it right ? Validation : Did we make the right thing ?
MIPS product development process
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 36/39
www.mips.be
DC: Validation process - Customer level
End Beta Testing
GA Release
Beta Test
Scenarios
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 37/39
www.mips.be
Certification and audits External audits:
ISO 9001 certified by ISOQAR Scope: Development, deployment, sales and support MIPS Gent and MIPS France
Astrazenica – bioMérieux
Internal audits
Procedure in place that defines who should dowhat in case of a major defect in the field Customers
Corrective measures Undo the mistake
Preventive measures Work-around Install new version
8/2/2019 4 Acke MIPS Version 2
http://slidepdf.com/reader/full/4-acke-mips-version-2 38/39
www.mips.be
Conclusions
By improving on a continuous basis it’s
People Processes Products
MIPS tries to prevent any defects in his SW products
“You get what you inspect, not what you expect…”